Feedback PLC Bleepa selected for WISH 2020 Innovation Awards
November 05 2020 - 1:01AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
05 November 2020
Feedback plc
Bleepa selected for WISH 2020 Innovation Awards Programme
-- World Innovation Summit for Health ("WISH") - 15-19 November 2020
-- Named as a WISH 2020 Innovation Booster
-- Year-long prestigious awards programme enables access to key Middle-East healthcare markets
London, 5 November 2020: Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist medical imaging technology company,
announces that Bleepa has been selected as a WISH 2020 Innovation
Booster at the World Innovation Summit for Health, 15-19 November
2020 in Doha, Qatar.
The WISH 2020 Innovation Booster
The WISH Innovation Booster provides a chance for entrepreneurs
to exhibit their healthcare innovations in front of some of the
world's leading health experts, health ministers, decision-makers,
and investors. WISH provides a platform to enable delegates to
engage with these cutting-edge ideas that are changing healthcare
from the ground up.
The WISH 2020 Innovation Booster programme represents some of
the world's most exciting healthcare innovations, ranging from
practical devices and business models to design-based solutions.
Companies showcasing their innovations share a common goal: driving
improvement and excellence in healthcare. Each innovation showcase
has the potential to transform global health, both reducing the
costs of healthcare delivery and improving the quality of care for
patients.
Dr Tom Oakley, CEO of Feedback, commented:
"We are delighted to have been accepted for the prestigious
virtual WISH programme which is a dedicated showcasing event into
the Middle-Eastern healthcare markets. Every year, WISH selects a
handful of products from around the world that it really wants to
champion and promote, and it awards them a WISH fellowship,
providing a year-long dedicated programme of support to launch
those products into the Middle-Eastern market and we are proud to
say that Bleepa has been chosen as one of their WISH 2020
Innovation Boosters. This represents a fantastic opportunity for us
to really promote Bleepa into the Middle-East."
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint
Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited
(Joint Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236 or
Johnson 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a medical imaging technology
business. Its core product, Bleepa, is a revolutionary medical
imaging communications app, providing an easy-to-use, high quality
tool to enable remote and secure communications between front-line
clinicians and teams. Importantly, it is the only CE marked medical
imaging communications platform on the NHSx clinical communications
tools framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS")-based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care facilitators. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of diagnosis.
About WISH
We forge connections and help build action-driven communities of
knowledge who work together to address today's most pressing global
healthcare challenges.
We convene and collaborate with the world's leading experts and
the highest levels of decision-makers.
We create and disseminate world-class, evidence-based content
and knowledge.
We promote active learning and support within and between
communities.
We contribute to the vision and mission of Qatar Foundation for
Education, Science and Community Development and Qatar National
Vision 2030, and serve to underscore Qatar's pioneering role as an
emerging center for healthcare innovation.
We showcase innovations that will make a difference for
healthcare communities everywhere.
We aim to influence healthcare policy globally.
https://2020.wish.org.qa/about-wish/
About RNS Reach announcements
This is an RNS Reach announcement. RNS Reach is an investor
communication service aimed at assisting listed and unlisted
(including AIM quoted) companies to distribute media only /
non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an
RNS regulatory announcement and not on RNS Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEAXFLEANEFFA
(END) Dow Jones Newswires
November 05, 2020 02:01 ET (07:01 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Apr 2023 to Apr 2024
